DrugDashboards

Venlafaxine Hydrochloride

Venlafaxine · VENLAFAXINE HYDROCHLORIDE 75 mg/1 · Tablet, Extended Release · Oral · Rising Pharma Holdings, Inc.

NDC 64980-0579-03 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. The generic price has fallen 66% in a year, to $0.2843 per unit — and generics that get this cheap tend to get abandoned rather than defended. The brand (venlafaxine) runs $6.18 per unit 17× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2843per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.3645per TABweighted avg manufacturer price $0.2083 · Aug 1, 2026128% of what pharmacies pay — higher than 71% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Dec 2023Sep 2026$0.2843
33 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$8.53
#90 count
$25.59

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$16,005
436 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

15Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 64% year over year+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for venlafaxine (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA216044
TE code
AB
Approval date
Nov 28, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Venlafaxine (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Remedyrepack Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 3, 2026
Ajanta Pharma USA Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.VENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.VENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Almatica Pharma LLCVENLAFAXINE BESYLATE MONOHYDRATE 112.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCVENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCVENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCVENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCVENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesVENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesVENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesVENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesVENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.VENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.VENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.VENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedVENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedVENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedVENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedVENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.VENLAFAXINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.VENLAFAXINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.VENLAFAXINE HYDROCHLORIDE 225 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.VENLAFAXINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Venlafaxine Hydrochloride — NDC 64980-0579-03," retrieved September 3, 2026, https://drugdashboards.com/drug/64980057903.

Free to cite with attribution — see how the data is put together.